FDA Approves First Topical Gene Therapy for Dystrophic Epidermolysis Bullosa Wounds
U.S. Food and Drug Administration
Around 65 percent of the wounds treated with Vyjuvek showed complete wound closure in DEB patients
Therapeutics
Exome Sequencing Identifies Patients with HBOC Missed by Current Screening Guidelines
American Association for Cancer Research
Current guidelines ruled 60 percent of individuals identified with HBOC risk as ineligible for genetic testing
Artificial Pancreas Benefits Adults and Children with Diabetes
University of Virginia Health System
Average user spent 2.8 more hours per day in the target blood sugar range
FDA Amends EUAs to Simplify Use of Bivalent mRNA COVID-19 Vaccines
U.S. Food and Drug Administration
Unvaccinated individuals may receive a single dose of a bivalent vaccine, not multiple doses of the monovalent mRNA vaccines
Brain Networks Involved in Epileptic Seizures Identified
University College London
Surgically disconnecting specific networks in the brain may help patients live epilepsy-free for a longer time
Daily Statin Dose May Reduce CVD Risk in HIV Patients
National Institutes of Health
Per Data Safety and Monitoring Board, the benefits of using pitavastatin daily outweighed any risks
STI Epidemic Showed No Signs of Slowing in 2021 in the US
Centers for Disease Control and Prevention
Experts urge stakeholders to create and implement innovative prevention approaches and promising new tools
The Endocrine Society Alarmed as TX Court Bans Mifepristone
The Endocrine Society
Decision significantly impacts endocrine disease treatment, drug approval process, and access to reproductive care
Pancreatic Lesions May Occur Earlier than Previously Thought
American Association for Cancer Research
Researchers partnered with Gift Of Life Michigan to analyze healthy pancreata from deceased donors
Key Mechanisms of NK Cell Dysfunction Revealed
university of science and technology of china
Study explains how tumors evade natural killer cells’ response from a membrane topology perspective, offers new immunotherapy strategies
AACR Applauds, Backs NCI’s National Cancer Plan
American Association for Cancer Research
Comprehensive plan provides an updated roadmap and strategies to end cancer as we know it
NIH Trial Reveals Promising Therapy for Rare Bone Disorder
National Institutes of Health
Medication is the first to reduce the bone-weakening process in patients with fibrous dysplasia
Moderna CEO Justifies Price Hike, Denies NIH as Vaccine Co-Creators
Swathi Kodaikal, MSc
“The price is not linked to the company’s performance, the price is linked to the value of the product,” says Stéphane Bancel, Moderna CEO
Study Reveals Single Mutation Behind Episodic Ataxia Type 6
University of Groningen
Mutation changes result in an ionic imbalance in the neurons that ultimately weakens control and coordination
Shape-Shifting Antibiotics to Combat Drug-Resistant Bacteria
Cold Spring Harbor Laboratory
Click chemistry can help design a wide range of shape-shifting antibiotics that may effectively combat multi-drug resistant bacteria
Pediatric Crohn’s Disease Clinical Trial Yields Game-Changing Outcomes
University of North Carolina School of Medicine
Findings revealed the efficacy of anti-TNF inhibitors monotherapy versus combination therapy with anti-TNF inhibitors and immunosuppressants
Water Quality Control Throughout the Drug Pipeline
Today's Clinical Lab
Download this white paper to understand how pure water can help your lab troubleshoot QC and ensure compliance throughout the drug pipeline
FDA Compliance and Quality Control of Drugs Requires Pure Water
Today's Clinical Lab
Download this white paper to learn about FDA 483 compliance and quality control of your drug pipeline, and how water purification can help with that
New Immunotherapy Delivery Option for Leptomeningeal Disease in Cancer Patients
University of Texas MD Anderson Cancer Center
Concurrent intrathecal and intravenous treatment is safe and improves outcomes in a subset of patients with melanoma
SAGE Updates COVID-19 Vaccination Guidance
World Health Organization
Roadmap prioritizes recipients based on age, medical history, and other factors and shares new recommendations on booster doses